InvestorsHub Logo
Followers 6
Posts 355
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Sunday, 04/07/2019 11:04:27 AM

Sunday, April 07, 2019 11:04:27 AM

Post# of 403104
Isradipine revenues already INCREASING!!!!

Elite Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of Fiscal Year 2019

"Consolidated revenues for the Third Quarter were $2.7 million, an increase of approximately 6% as compared to revenues for the comparable quarter of the prior fiscal year. The increase in revenues was largely attributed to the launch of Elite's methadone products during the quarter and increases in revenues relating to the manufacture and sale of Isradipine, Phentermine and Naltrexone."

After Dr. Tanya Simuni's presentation at the 2019 AAN Annual Meeting we will see even more increases in revenues from Isradipine$$$$$$$$

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News